Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 6.

Kirovski, G; Stevens, A P; Czech, B; Dettmer, K; Weiss, T S; Wild, P; Hartmann, A; Bosserhoff, A K; Oefner, P J; Hellerbrand, C (2011). Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA). American Journal of Pathology, 178(3):1145-1152.

Meyer, S; Wild, P J; Vogt, T; Bataille, F; Ehret, C; Gantner, S; Landthaler, M; Klinkhammer-Schalke, M; Hofstaedter, F; Bosserhoff, A K (2010). Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma. Experimental Dermatology, 19(8):e251-e257.

Amann, T; Bataille, F; Spruss, T; Dettmer, K; Wild, P J; Liedtke, C; Mühlbauer, M; Kiefer, P; Oefner, P J; Trautwein, C; Bosserhoff, A K; Hellerbrand, C (2010). Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth. American Journal of Pathology, 176(3):1433-1442.

Massoumi, R; Kuphal, S; Hellerbrand, C; Haas, B; Wild, P; Spruss, T; Pfeifer, A; Fässler, R; Bosserhoff, A K (2009). Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma. Journal of Experimental Medicine, 206(1):221-232.

Winklmeier, A; Poser, I; Hoek, K S; Bosserhoff, A K (2009). Loss of full length CtBP1 expression enhances the invasive potential of human melanoma. BMC Cancer, 9:52.

Hellerbrand, C; Amann, T; Schlegel, J; Wild, P; Bataille, F; Spruss, T; Hartmann, A; Bosserhoff, A K (2008). The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma. Gut, 57(2):243-251.

This list was generated on Thu Jul 18 07:15:28 2019 CEST.